Pirfenidone NDC 59651-244

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-244Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0244Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
59651-244-27	59651024427	1 BOTTLE in 1 CARTON (59651-244-27) / 270 CAPSULE in 1 BOTTLEMarketed from Apr 20, 2026
59651-244-28	59651024428	4 BLISTER PACK in 1 CARTON (59651-244-28) / 63 CAPSULE in 1 BLISTER PACK (59651-244-63)Marketed from Apr 20, 2026
59651-244-42	59651024442	1 BLISTER PACK in 1 CARTON (59651-244-42) / 63 CAPSULE in 1 BLISTER PACKMarketed from Apr 20, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pirfenidone
Generic name (nonproprietary): pirfenidone
Active ingredients: Pirfenidone — 267 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Aurobindo Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212597
Marketing start: Apr 20, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Pyridones (Chemical structure)
Identifiers: Product ID 59651-244_3115f15f-171c-4266-8dc8-5655f56e6accSPL ID 3115f15f-171c-4266-8dc8-5655f56e6accSPL set ID 3115f15f-171c-4266-8dc8-5655f56e6accRxCUI 1592279UNII D7NLD2JX7U
Pharmacologic class: Pyridone

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651024427 followed by a unit qualifier and the quantity

Package 59651-0244-27. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 22, 2026.

Indications (excerpt from the label)

Pirfenidone capsules are indicated for the treatment of idiopathic pulmonary fibrosis (IPF). Pirfenidone is a pyridone indicated for the treatment of idiopathic pulmonary fibrosis (IPF). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)